These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 30592329

  • 1. Knockdown of SLC34A2 inhibits cell proliferation, metastasis, and elevates chemosensitivity in glioma.
    Bao Z, Chen L, Guo S.
    J Cell Biochem; 2019 Jun; 120(6):10205-10214. PubMed ID: 30592329
    [Abstract] [Full Text] [Related]

  • 2. Knockdown of SLC34A2 Inhibits Hepatocellular Carcinoma Cell Proliferation and Invasion.
    Li Y, Chen X, Lu H.
    Oncol Res; 2016 Oct 27; 24(6):511-519. PubMed ID: 28281971
    [Abstract] [Full Text] [Related]

  • 3. Hypoxia induced ferritin light chain (FTL) promoted epithelia mesenchymal transition and chemoresistance of glioma.
    Liu J, Gao L, Zhan N, Xu P, Yang J, Yuan F, Xu Y, Cai Q, Geng R, Chen Q.
    J Exp Clin Cancer Res; 2020 Jul 16; 39(1):137. PubMed ID: 32677981
    [Abstract] [Full Text] [Related]

  • 4. Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis.
    Tang JH, Yang L, Chen JX, Li QR, Zhu LR, Xu QF, Huang GH, Zhang ZX, Xiang Y, Du L, Zhou Z, Lv SQ.
    Cancer Commun (Lond); 2019 Dec 03; 39(1):81. PubMed ID: 31796105
    [Abstract] [Full Text] [Related]

  • 5. SLC34A2 simultaneously promotes papillary thyroid carcinoma growth and invasion through distinct mechanisms.
    He J, Zhou M, Li X, Gu S, Cao Y, Xing T, Chen W, Chu C, Gu F, Zhou J, Jin Y, Ma J, Ma D, Zou Q.
    Oncogene; 2020 Mar 03; 39(13):2658-2675. PubMed ID: 32005974
    [Abstract] [Full Text] [Related]

  • 6. Knockdown of TRIM47 inhibits glioma cell proliferation, migration and invasion through the inactivation of Wnt/β-catenin pathway.
    Chen L, Li M, Li Q, Xu M, Zhong W.
    Mol Cell Probes; 2020 Oct 03; 53():101623. PubMed ID: 32603762
    [Abstract] [Full Text] [Related]

  • 7. Nobiletin inhibits invasion via inhibiting AKT/GSK3β/β-catenin signaling pathway in Slug-expressing glioma cells.
    Zhang X, Zheng K, Li C, Zhao Y, Li H, Liu X, Long Y, Yao J.
    Oncol Rep; 2017 May 03; 37(5):2847-2856. PubMed ID: 28339056
    [Abstract] [Full Text] [Related]

  • 8. MicroRNA-200b inhibits the growth and metastasis of glioma cells via targeting ZEB2.
    Li J, Yuan J, Yuan X, Zhao J, Zhang Z, Weng L, Liu J.
    Int J Oncol; 2016 Feb 03; 48(2):541-50. PubMed ID: 26648487
    [Abstract] [Full Text] [Related]

  • 9. GASC1 promotes glioma progression by enhancing NOTCH1 signaling.
    Xiao Z, Yang X, Liu Z, Shao Z, Song C, Zhang K, Wang X, Li Z.
    Mol Med Rep; 2021 May 03; 23(5):. PubMed ID: 33649841
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of MMP14 potentiates the therapeutic effect of temozolomide and radiation in gliomas.
    Ulasov I, Thaci B, Sarvaiya P, Yi R, Guo D, Auffinger B, Pytel P, Zhang L, Kim CK, Borovjagin A, Dey M, Han Y, Baryshnikov AY, Lesniak MS.
    Cancer Med; 2013 Aug 03; 2(4):457-67. PubMed ID: 24156018
    [Abstract] [Full Text] [Related]

  • 11. Heparanase confers temozolomide resistance by regulation of exosome secretion and circular RNA composition in glioma.
    Si J, Li W, Li X, Cao L, Chen Z, Jiang Z.
    Cancer Sci; 2021 Sep 03; 112(9):3491-3506. PubMed ID: 34036683
    [Abstract] [Full Text] [Related]

  • 12. Down-regulation of ABCE1 inhibits temozolomide resistance in glioma through the PI3K/Akt/NF-κB signaling pathway.
    Zhang P, Chen XB, Ding BQ, Liu HL, He T.
    Biosci Rep; 2018 Dec 21; 38(6):. PubMed ID: 30455394
    [Abstract] [Full Text] [Related]

  • 13. MiR-181b-5p modulates chemosensitivity of glioma cells to temozolomide by targeting Bcl-2.
    Zhang X, Yu J, Zhao C, Ren H, Yuan Z, Zhang B, Zhuang J, Wang J, Feng B.
    Biomed Pharmacother; 2019 Jan 21; 109():2192-2202. PubMed ID: 30551476
    [Abstract] [Full Text] [Related]

  • 14. MicroRNA-410 acts as oncogene in NSCLC through downregulating SLC34A2 via activating Wnt/β-catenin pathway.
    Zhang X, Ke X, Pu Q, Yuan Y, Yang W, Luo X, Jiang Q, Hu X, Gong Y, Tang K, Su X, Liu L, Zhu W, Wei Y.
    Oncotarget; 2016 Mar 22; 7(12):14569-85. PubMed ID: 26910912
    [Abstract] [Full Text] [Related]

  • 15. Knockdown of circHIPK3 Facilitates Temozolomide Sensitivity in Glioma by Regulating Cellular Behaviors Through miR-524-5p/KIF2A-Mediated PI3K/AKT Pathway.
    Yin H, Cui X.
    Cancer Biother Radiopharm; 2021 Sep 22; 36(7):556-567. PubMed ID: 32833501
    [Abstract] [Full Text] [Related]

  • 16. MicroRNA-34a-5p suppresses tumorigenesis and progression of glioma and potentiates Temozolomide-induced cytotoxicity for glioma cells by targeting HMGA2.
    Ma S, Fu T, Zhao S, Gao M.
    Eur J Pharmacol; 2019 Jun 05; 852():42-50. PubMed ID: 30851271
    [Abstract] [Full Text] [Related]

  • 17. Mutant IDH1 Enhances Temozolomide Sensitivity via Regulation of the ATM/CHK2 Pathway in Glioma.
    Lin L, Cai J, Tan Z, Meng X, Li R, Li Y, Jiang C.
    Cancer Res Treat; 2021 Apr 05; 53(2):367-377. PubMed ID: 33070553
    [Abstract] [Full Text] [Related]

  • 18. Solute carrier family 34 member 2 overexpression contributes to tumor growth and poor patient survival in colorectal cancer.
    Liu L, Yang Y, Zhou X, Yan X, Wu Z.
    Biomed Pharmacother; 2018 Mar 05; 99():645-654. PubMed ID: 29653487
    [Abstract] [Full Text] [Related]

  • 19. Knockdown of lncRNA HOXD-AS1 suppresses proliferation, migration and invasion and enhances cisplatin sensitivity of glioma cells by sponging miR-204.
    Zhou H, Ma Y, Zhong D, Yang L.
    Biomed Pharmacother; 2019 Apr 05; 112():108633. PubMed ID: 30784927
    [Abstract] [Full Text] [Related]

  • 20. A complex mechanism for HDGF-mediated cell growth, migration, invasion, and TMZ chemosensitivity in glioma.
    Song Y, Hu Z, Long H, Peng Y, Zhang X, Que T, Zheng S, Li Z, Wang G, Yi L, Liu Z, Fang W, Qi S.
    J Neurooncol; 2014 Sep 05; 119(2):285-95. PubMed ID: 24986090
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.